The Omicron COVID-19 Symptoms That Infectious Disease Experts Want You to Know About
Here’s a big caveat that experts are stressing: The patients that Dr. Coetzee referred to were young and otherwise healthy—people who typically have more mild cases of COVID-19 to begin with. The majority of the Omicron patients in the CDC study were also fully vaccinated. “Those individuals already tend to have milder infections,” says William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine.
“I haven't heard a lot on people losing their sense of taste and smell with Omicron, but I’m willing to bet that this variant can do that, cause shortness of breath, and all of the other symptoms of COVID-19, particularly in the unvaccinated,” Dr. Russo says. “We just don’t have a lot of data yet.”
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mainland China reports its first omicron Covid caseThe omicron case was found in a traveler from overseas, who showed no symptoms but tested positive on Thursday, according to Tianjin's local health commission.
Read more »
U.S. crosses 50 million COVID-19 cases as Delta dominates amid Omicron emergenceThe United States crossed 50 million coronavirus cases on Sunday, according to Reuters tally, as the Delta variant continues to threaten Americans and the newly discovered Omicron variant spreads.
Read more »
What we know about Omicron COVID variant symptoms as CDC, WHO release updatesThe variant is spreading rapidly around the world, though information on how seriously ill people fall after catching it is still limited.
Read more »
Major study finds omicron more vaccine resistant, causes milder illness in South AfricaThe omicron Covid-19 variant appeared to cause less severe illness in South Africa but was more resistant to the Pfizer vaccine, according to the first major real-world study
Read more »
Pfizer confirms COVID pill's results, potency versus omicronPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that omicron uses to reproduce itself.
Read more »
Omicron now in the District, Maryland and Virginia, with first case present for weeksThe omicron variant of the coronavirus has been detected across the region as of the weekend.
Read more »